ALL OF OUR PRODUCTS ARE DESIGNED TO MAXIMIZE THE DISEASE FIGHTING ANTIOXIDANT LEVELS IN THE KERATOCONIC CORNEA
WHICH PROTECTS AGAINST THE OXIDATIVE STRESS THAT IS A MAIN CAUSE OF KERATOCONUS
Many studies indicate an abnormal processing of superoxide (O-) free radicals in the keratoconic cornea resulting in corneal damage as a result of oxidative stress (OS) in the development and progression of this disease.
As cited in numerous scientific studies from around the world, (many of which are posted on this website for your perusal [See The Science Behind our Products heading on the top of this page], keratoconic corneas seems to lack the ability to self-repair the cumulative oxidative damage easily repaired by normal corneas. Like any tissues in the body, the cornea creates many harmful byproducts of cell metabolism called free radicals. Normal corneas, like any other body tissue, have a defense system in place to neutralize these free radicals so they don’t damage the collagen stromal layer, the structural part of the cornea, weakening it and causing the cornea to thin and bulge.
Since the keratoconic cornea does not possess the ability to eliminate the free radicals, they accumulate in the tissue and can ultimately cause structural damage resulting in a change in corneal shape, loss of corneal clarity and subsequently a loss of vision.
The formulation in our Stabil-Eyez supplement has a proprietary dosage of just the right types and amounts of antioxidant nutrients, as supported by scientific research, that the keratoconic cornea needs to better defend against these tissue changes.
We are in the final research and development stages of a new and exciting product. It builds on the same science as the Stabil-Eyez oral supplement but with a somewhat complimentary delivery system by providing additional antioxidants directly to the corneal tissue in a topical (eyedrop) form. This product was designed to be used in concert with the oral supplement to "top off" the antioxidant levels in the cornea and to provide an additive or synergistic effect, although it will also be available as a stand alone treatment. Will be available in Fall 2020. Please periodically check our website or subscribe to our newsletter to get the latest on its release date.